Filter Results :

Your search for Neural returned 29 reports

Sort by


Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016

22 Jun 2016  |  Published by:  Global Markets Direct
Summary‘Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neural Apoptosis-Regulated Convertase 1 or PCSK9 or EC 3.4.21.) - Pipeline Review, H1 2016’, provides in depth analysis on Proprotein Convertase Subtilisin/Kexin Type 9 (Proprotein Convertase 9 or Neura...

$ 3,500.00

Read More

Global Neuralgia Partnering 2010-2016

01 Jun 2016  |  Published by:  CurrentPartnering
The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • Trends in partnering deals • Top deals by value • Deals listed by company A-Z, industry secto...

$ 1,495.00

Read More

Neuralstem, Inc. (CUR) - Financial and Strategic SWOT Analysis Review

15 Apr 2016  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company that develops and markets medicines based on human neural stem cell technology and cell therapy. The company provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis...

$ 300.00

Read More

Neuralstem, Inc. (CUR) - Medical Equipment - Deals and Alliances Profile

15 Apr 2016  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company that develops and markets medicines based on human neural stem cell technology and cell therapy. The company provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis...

$ 250.00

Read More

Postherpetic Neuralgia - Pipeline Review, H1 2016

13 Apr 2016  |  Published by:  Global Markets Direct
Summary‘Postherpetic Neuralgia - Pipeline Review, H1 2016’, provides an overview of the Postherpetic Neuralgia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Postherpetic Neuralgia, complete with analysis by stage of development, drug targ...

$ 2,000.00

Read More

Trigeminal Neuralgia - Pipeline Review, H1 2016

22 Mar 2016  |  Published by:  Global Markets Direct
Summary‘Trigeminal Neuralgia - Pipeline Review, H1 2016’, provides an overview of the Trigeminal Neuralgia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Trigeminal Neuralgia, complete with analysis by stage of development,...

$ 2,000.00

Read More

Neuralstem, Inc. (CUR) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

14 Mar 2016  |  Published by:  GlobalData
SummaryNeuralstem, Inc. (Neuralstem) is a pharmaceutical company that develops and markets medicines based on human neural stem cell technology and cell therapy. The company provides cell therapy treatment for ALS, ischemic stroke, spinal cord injury, glioblastoma, multiple sclerosis, optic neuritis...

$ 250.00

Read More

Acute Sensorineural Hearing Loss - Pipeline Review, H1 2016

24 Feb 2016  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Acute Sensorineural Hearing Loss - Pipeline Review, H1 2016’, provides an overview of the Acute Sensorineural Hearing Loss pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Sensorineural Hearing Loss, co...

$ 2,000.00

Read More

Postherpetic Neuralgia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

01 Jan 2016  |  Published by:  DelveInsight
SummaryDelveInsight’s, Postherpetic Neuralgia-API Insights, 2015,report provides Postherpetic Neuralgia drugs marketed details and API Manufacturers details across the globe along with the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by...

$ 1,250.00

Read More

Postherpetic Neuralgia Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jan 2016  |  Published by:  DelveInsight
Summary'Postherpetic Neuralgia- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API ...

$ 2,000.00

Read More

Acute Sensorineural Hearing Loss-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Acute Sensorineural Hearing Loss- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Acute Sensorineural Hearing Loss. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in...

$ 1,250.00

Read More

Neuralgia-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Neuralgia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Neuralgia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Neura...

$ 1,250.00

Read More

Postherpetic Neuralgia-Pipeline Insights, 2016

01 Jan 2016  |  Published by:  DelveInsight
Summary Postherpetic Neuralgia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Postherpetic Neuralgia. The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-l...

$ 1,250.00

Read More

Sredneural'skiy medeplavil'nyi zavod (SUMZ) - Company Capsule

04 Nov 2015  |  Published by:  World Market Intelligence
Synopsis"Sredneural'skiy medeplavil'nyi zavod (SUMZ) - Company Capsule" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, financial ratios, financial analysis, key employees.SummaryThis report...

$ 75.00

Read More

Hearing Aids Market by Product (Receiver-In-The-Ear, Behind-The-Ear, In-The-Ear, Canal Hearing Aids, Cochlear Implants, Bone Anchored Systems), Hearing Loss (Sensorineural, Conductive), End-User (Adults, Pediatrics) - Global Forecasts to 2020

02 Nov 2015  |  Published by:  MarketsandMarkets
The hearing aids market is expected to reach USD 8,373.9 million by 2020 from USD 6,183.3 million in 2015, at a CAGR of 6.3%. The global hearing aids market is segmented based on products, type of hearing loss, end-users, and regions. The hearing implants segment is expected to register the highest ...

$ 4,650.00

Read More
Total 29 records.